Suppr超能文献

成骨刺激和VEGF治疗对接种人骨髓间充质干细胞的松质骨支架体内骨形成的影响。

Influence of osteogenic stimulation and VEGF treatment on in vivo bone formation in hMSC-seeded cancellous bone scaffolds.

作者信息

Lenze Ulrich, Pohlig Florian, Seitz Sebastian, Ern Christina, Milz Stefan, Docheva Denitsa, Schieker Matthias

机构信息

Laboratory of Experimental Surgery and Regenerative Medicine, Department of Surgery, University of Munich (LMU), Munich, Germany.

出版信息

BMC Musculoskelet Disord. 2014 Oct 16;15:350. doi: 10.1186/1471-2474-15-350.

Abstract

BACKGROUND

Tissue engineering approaches for reconstruction of large bone defects are still technically immature, especially in regard to sufficient blood supply. Therefore, the aim of the present study was to investigate the influence of osteogenic stimulation and treatment with VEGF on new bone formation and neovascularization in hMSC-loaded cancellous bone scaffolds in vivo.

METHODS

Cubic scaffolds were seeded with hMSC and either cultured in stem cell medium or osteogenic stimulation medium. One osteogenically stimulated group was additionally treated with 0.8 μg VEGF prior to subcutaneous implantation in athymic mice. After 2 and 12 weeks in vivo, constructs and selected organs were harvested for histological and molecular analysis.

RESULTS

Histological analysis revealed similar vascularization of the constructs with and without VEGF treatment and absence of new bone formation in any group. Human DNA was detected in all inoculated scaffolds, but a significant decrease in cells was observed after 2 weeks with no further decrease after 12 weeks in vivo.

CONCLUSION

Under the chosen conditions, osteogenic stimulation and treatment with VEGF does not have any influence on the new bone formation and neovascularization in hMSC-seeded cancellous bone scaffolds.

摘要

背景

用于重建大骨缺损的组织工程方法在技术上仍不成熟,尤其是在充足血供方面。因此,本研究的目的是调查成骨刺激和血管内皮生长因子(VEGF)治疗对体内接种人骨髓间充质干细胞(hMSC)的松质骨支架中新骨形成和血管生成的影响。

方法

将hMSC接种到立方体支架上,并在干细胞培养基或成骨刺激培养基中培养。一个成骨刺激组在皮下植入无胸腺小鼠之前额外用0.8μg VEGF处理。体内2周和12周后,收获构建体和选定器官进行组织学和分子分析。

结果

组织学分析显示,无论是否用VEGF处理,构建体的血管化情况相似,且所有组均未观察到新骨形成。在所有接种的支架中均检测到人类DNA,但体内2周后细胞数量显著减少,12周后未进一步减少。

结论

在所选条件下,成骨刺激和VEGF治疗对接种hMSC的松质骨支架中的新骨形成和血管生成没有任何影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a84f/4216837/3825dce907a6/12891_2014_Article_2289_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验